PTPA and familial dilated cardiomyopathy: We now show that expression of the PBD PP2A anchoring disruptor peptide using an AAV gene therapy vector improves the cardiac structure and function of a DCM mouse model, including significantly increased left ventricular systolic function and normalized cardiomyocyte length:width ratio.